This clinical trial is focused on studying the long-term effects of a medication called Mirikizumab in individuals with Crohn’s Disease. Crohn’s Disease is a chronic inflammatory condition that affects the digestive tract, causing symptoms like abdominal pain, diarrhea, and weight loss. The medication being tested, Mirikizumab, is administered as a solution for injection and is designed to help manage the symptoms of this disease.

The purpose of this study is to evaluate how effective and safe Mirikizumab is over an extended period. Participants in the study will receive Mirikizumab and will be monitored to see how well the medication works in reducing the symptoms of Crohn’s Disease. The study will also assess the safety of the medication to ensure it is well-tolerated by those taking it.

Throughout the study, participants will receive regular injections of Mirikizumab and will have scheduled visits with healthcare professionals to track their progress. The study aims to provide valuable information on the long-term use of Mirikizumab for managing Crohn’s Disease, helping to improve treatment options for those affected by this condition.